These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4466933)

  • 1. [Blast transformation of lymphocytes in lymphogranulomatosis].
    Simbirtseva GD; Petrasheva NI
    Klin Med (Mosk); 1974 Mar; 52(3):124-8. PubMed ID: 4466933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various immunomorphological tests of cellular immunity in lymphogranulomatosis].
    Gelenko AM
    Arkh Patol; 1979; 41(1):18-21. PubMed ID: 106807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Capacity of lymphocytes from persons with lymphogranulomatosis for blast transformation in vitro under the effect of phytohemagglutin].
    Slavnaia IL; Kaiumova MG
    Lab Delo; 1972; 4():208-12. PubMed ID: 4119837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of blast transformation of lymphocytes and certain problems of pathogenesis of lymphogranulomatosis].
    Martynov SM; Loginskiĭ VE; Polishchuk RS
    Probl Gematol Pereliv Krovi; 1974 Mar; 19(3):24-8. PubMed ID: 4545491
    [No Abstract]   [Full Text] [Related]  

  • 5. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum and immunological studies in patients with lymphomas. 13. Examination of cellular immunity by specific and nonspecific stimulants].
    Giraudo Conesa LC; Braun M; Pavlovsky A; Bachmann AE
    Sangre (Barc); 1973; 18(3):305-12. PubMed ID: 4800716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of cell mediated immunity in Hodgkin's disease (apropos of 30 cases)].
    Laurens A; Morin A; Aubry J; Laurent G; Audreu G; Hainaut J
    Ann Med Interne (Paris); 1975 Dec; 126(12):829-36. PubMed ID: 1225093
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cellular immunity indices in lymphogranulomatosis].
    Baĭsogolov GD; Pavlov VV; Konopliannikov AG; Kozlov VM; Kulish IuS
    Sov Med; 1981; (6):29-34. PubMed ID: 6974405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic aspects of lymphogranulomatosis].
    Bogomolov EL; Vermel' AE; Dvoretskiĭ LI; Lorie IuI
    Ter Arkh; 1972 May; 44(5):10-6. PubMed ID: 4562560
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the radiation therapy of lymphogranulomatosis according to immunoreactivity data].
    Khvorostenko MI
    Med Radiol (Mosk); 1980 Jan; 25(1):37-41. PubMed ID: 7354712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Humoral and cellular immunologic deficiency in lymphogranulomatosis].
    Patakfalvy A; Balázs M; Simon K; Gógl A; Kovács Z
    Orv Hetil; 1972 Nov; 113(45):2704-7. PubMed ID: 5083235
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
    Rühl H; Vogt W; Bochert G; Schmidt S; Schaoua H; Moelle R
    Clin Exp Immunol; 1974 Jul; 17(3):407-15. PubMed ID: 4468860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity disorders in malignant lymphomas].
    Stefanović S; Spuzić I; Ristić M; Pendić S; Ercegovac V
    Srp Arh Celok Lek; 1977; 105(3-4):245-52. PubMed ID: 929326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C; De Sanctis C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional activity of T-lymphocytes in hemoblastoses].
    Raushenbakh MO; Kruglova GV; Kaverzneva MM; Vasil'eva ER; Bykovskaia SN
    Vestn Akad Med Nauk SSSR; 1978; (5):47-53. PubMed ID: 307879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of the immunological indices in lymphogranulomatosis following splenectomy and radiation therapy].
    Ankudinov VA; Asliaev LA; Khvorostenko MI; Krugovov BA; Kosse VA
    Vopr Onkol; 1981; 27(4):26-31. PubMed ID: 7233871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.